journal article·2018-02Open access

Nanoformulation of Brain‐Derived Neurotrophic Factor with Target Receptor‐Triggered‐Release in the Central Nervous System

Yuhang Jiang, James M. Fay, Chi‐Duen Poon, Natasha Vinod, Yuling Zhao, Kristin Bullock, Si Qin, Devika S Manickam, Xiang Yi, William A. Banks, Alexander V. Kabanov

Advanced Functional Materials· Volume 28· Issue 6

Abstract

Abstract Brain‐derived neurotrophic factor (BDNF) is identified as a potent neuroprotective and neuroregenerative agent for many neurological diseases. Regrettably, its delivery to the brain is hampered by poor serum stability and rapid brain clearance. Here, a novel nanoformulation is reported composed of a biocompatible polymer, poly(ethylene glycol)‐b‐poly(l‐glutamic acid) (PEG‐PLE), that hosts the BDNF molecule in a nanoscale complex, termed here Nano‐BDNF. Upon simple mixture, Nano‐BDNF spontaneously forms uniform spherical particles with a core–shell structure. Molecular dynamics simulations suggest that binding between BDNF and PEG‐PLE is mediated through electrostatic coupling as well as transient hydrogen bonding. The formation of Nano‐BDNF complex stabilizes BDNF and protects it from nonspecific binding with common proteins in the body fluid, while allowing it to associate with its receptors. Following intranasal administration, the nanoformulation improves BDNF delivery throughout the brain and displays a more preferable regional distribution pattern than the native protein. Furthermore, intranasally delivered Nano‐BDNF results in superior neuroprotective effects in the mouse brain with lipopolysaccharides‐induced inflammation, indicating promise for further evaluation of this agent for the therapy of neurologic diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms · Vagus Nerve Stimulation Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy University of North Carolina Chapel Hill NC 27599‐7362 USA

Center for Nanotechnology in Drug Delivery Eshelman School of Pharmacy University of North Carolina Chapel Hill NC 27599‐7362 USA

Department of Biochemistry and Biophysics School of Medicine University of North Carolina Chapel Hill NC 27599‐7260 USA

Research Computer Center University of North Carolina Chapel Hill NC 27599 USA

Joint UNC/NC State Department of Biomedical Engineering University of North Carolina Chapel Hill NC 27599‐7575 USA

Geriatric Research Education and Clinical Center Veterans Affairs Puget Sound Health Care System Seattle WA 98108 USA

Division of Gerontology and Geriatric Medicine Department of Medicine University of Washington School of Medicine Seattle WA 98108 USA

Laboratory for Chemical Design of Bionanomaterials Faculty of Chemistry M.V. Lomonosov Moscow State University Moscow 117234 Russia

Funding

National Institutes of Health · International Rett Syndrome Foundation

References (53)

Show source-provided references
1. 10.1016/j.brainres.2017.03.02910.1016/j.brainres.2017.03.029 ↗
2. 10.1016/S0028-3908(98)00141-510.1016/S0028-3908(98)00141-5 ↗
3. 10.1016/j.jconrel.2014.06.01710.1016/j.jconrel.2014.06.017 ↗
4. 10.1016/j.addr.2011.11.00210.1016/j.addr.2011.11.002 ↗
5. 10.1038/jcbfm.2014.21510.1038/jcbfm.2014.215 ↗
6. 10.3109/1061186090331813410.3109/10611860903318134 ↗
7. 10.3109/17435390.2015.104832410.3109/17435390.2015.1048324 ↗
8. 10.1002/jbm.a.3225410.1002/jbm.a.32254 ↗
9. 10.1128/AEM.01466-1410.1128/AEM.01466-14 ↗
10. 10.1070/RC1982v051n09ABEH00292110.1070/RC1982v051n09ABEH002921 ↗
11. 10.1093/glycob/cwn08410.1093/glycob/cwn084 ↗
12. 10.1016/0003-2697(85)90190-310.1016/0003-2697(85)90190-3 ↗
13. Kabanov A. V. · ChemInform · 1995 · 2610.1002/chin.199528318 ↗
14. 10.1021/la051866r10.1021/la051866r ↗
15. 10.1021/ma00043a00310.1021/ma00043a003 ↗
16. 10.1021/la026542710.1021/la0265427 ↗
17. 10.1016/0032-3950(77)90236-210.1016/0032-3950(77)90236-2 ↗
18. 10.1006/jmbi.1994.133410.1006/jmbi.1994.1334 ↗
19. 10.1021/bi00013a00110.1021/bi00013a001 ↗
20. 10.1021/ma970803f10.1021/ma970803f ↗
21. 10.1070/RC2005v074n01ABEH00116510.1070/RC2005v074n01ABEH001165 ↗
22. c)Y.Jiang The University of North Carolina at Chapel Hill 2016.
23. 10.1002/masy.20075050410.1002/masy.200750504 ↗
24. 10.1021/la051017410.1021/la0510174 ↗
25. 10.1134/S160767290904005X10.1134/S160767290904005X ↗
26. 10.1023/A:101103442589610.1023/A:1011034425896 ↗
27. 10.1006/exnr.1997.669910.1006/exnr.1997.6699 ↗
28. Nakamura T. · Oncogene · 1996 · 13 · 1111
29. 10.1002/jnr.2201210.1002/jnr.22012 ↗
30. 10.1007/s11095-009-0009-x10.1007/s11095-009-0009-x ↗
31. 10.1002/adma.20120063410.1002/adma.201200634 ↗
32. 10.1002/adfm.20090117210.1002/adfm.200901172 ↗
33. 10.1016/0092-8674(91)90396-G10.1016/0092-8674(91)90396-G ↗
34. 10.1001/archneurol.2011.23310.1001/archneurol.2011.233 ↗
35. 10.1007/s11095-011-0572-910.1007/s11095-011-0572-9 ↗
36. 10.1038/srep2859910.1038/srep28599 ↗
37. 10.1007/s11095-011-0572-910.1007/s11095-011-0572-9 ↗
38. 10.1002/pmic.20040117210.1002/pmic.200401172 ↗
39. 10.1126/scitranslmed.300359410.1126/scitranslmed.3003594 ↗
40. 10.1126/scitranslmed.300374810.1126/scitranslmed.3003748 ↗
41. 10.1016/j.jconrel.2016.12.03710.1016/j.jconrel.2016.12.037 ↗
42. 10.1016/j.pbb.2016.09.00310.1016/j.pbb.2016.09.003 ↗
43. 10.1523/JNEUROSCI.5503-09.201010.1523/JNEUROSCI.5503-09.2010 ↗
44. 10.1038/nm.191210.1038/nm.1912 ↗
45. 10.1007/s11060-013-1346-510.1007/s11060-013-1346-5 ↗
46. 10.1208/s12248-015-9724-x10.1208/s12248-015-9724-x ↗
47. 10.1016/j.jconrel.2015.06.02110.1016/j.jconrel.2015.06.021 ↗
48. 10.1016/j.jconrel.2016.02.03810.1016/j.jconrel.2016.02.038 ↗
49. 10.1160/TH14-04-036010.1160/TH14-04-0360 ↗
50. 10.1128/JVI.03671-1410.1128/JVI.03671-14 ↗
51. 10.1016/j.trsl.2017.08.00210.1016/j.trsl.2017.08.002 ↗
52. Bentivoglio M. · 1983
53. 10.1088/1742-6596/28/1/01710.1088/1742-6596/28/1/017 ↗